Welcome to our dedicated page for Alignment Healthcare news (Ticker: ALHC), a resource for investors and traders seeking the latest updates and insights on Alignment Healthcare stock.
Alignment Healthcare Inc (ALHC) operates as a Medicare Advantage health insurer serving seniors and individuals with chronic health conditions. The company's news coverage centers on Medicare Advantage market developments affecting its core business model of capitated healthcare delivery.
Key news categories for Alignment Healthcare include quarterly earnings reports that detail membership growth, medical loss ratios, and Star Ratings performance. The company's financial results reflect the operational dynamics of Medicare Advantage, where membership enrollment, clinical quality metrics, and care coordination efficiency determine profitability. Coverage of earnings releases provides insight into how the company manages the relationship between capitated revenue from CMS and medical costs for its member population.
Regulatory developments represent another significant news category, particularly CMS announcements regarding Medicare Advantage payment rates, Star Ratings methodology changes, and quality program adjustments. These policy decisions directly impact the company's revenue structure and competitive positioning within the Medicare Advantage market.
Partnership announcements and market expansion developments appear regularly in Alignment Healthcare's news flow. The company grows through both direct health plan operations in new markets and partnerships with regional insurers, making geographic expansion and partnership agreements material events for investors tracking the company's growth trajectory.
Clinical quality metrics, particularly Star Ratings results published annually by CMS, generate newsworthy developments as these ratings affect both revenue through quality bonus payments and member enrollment through plan comparison tools. Coverage of quality performance provides context on the company's care delivery effectiveness.
This news resource aggregates coverage from financial media, regulatory filings, and company announcements to provide a centralized view of developments affecting Alignment Healthcare's Medicare Advantage operations. Bookmark this page to track news impacting this healthcare services company.
Alignment Healthcare (NASDAQ: ALHC) has announced its participation in the upcoming William Blair 45th Annual Growth Stock Conference. The company's presentation is scheduled for Wednesday, June 4, at 2 p.m. CDT. Interested parties can access both the live webcast and replay of the presentation through Alignment's investor relations website at https://ir.alignmenthealth.com/.
Alignment Healthcare (NASDAQ: ALHC) has received the 2025 PQA Laura Cranston Excellence in Quality Award for its Medicare Advantage prescription drug (MAPD) plan. The company was one of only two MAPD plans out of 633 eligible contracts to achieve this recognition, representing the top 1.3%. The award requires a minimum 4.5-star Part D summary rating and a perfect 5-star rating on all five PQA medication measures used in CMS's star ratings program.
The recognition marks Alignment's sixth time receiving this honor, having previously won the PQA Excellence in Quality Award from 2018 to 2022. The company achieved perfect ratings in medication adherence for diabetes, hypertension, and cholesterol medications, as well as in medication therapy management program completion and statin use in persons with diabetes.
Alignment Healthcare (NASDAQ: ALHC) has announced its upcoming participation at the BofA Securities Healthcare Conference. The presentation is scheduled for Wednesday, May 14, at 2:20 p.m. PDT.
Interested parties can access both the live webcast and replay of the presentation through Alignment's investor relations website at https://ir.alignmenthealth.com/.
Alignment Healthcare (NASDAQ: ALHC) has announced two key leadership appointments to enhance its AI-enabled Medicare Advantage platform. Dr. Arta Bakshandeh has been named President of AVA®, the company's proprietary platform that utilizes 200+ data sources and 13,000+ attributes for personalized healthcare insights. Aly Duzich has been promoted to Chief Experience Officer to optimize member experience.
AVA platform leverages trusted AI to improve senior health outcomes and quality of care while reducing costs. The company has grown to over 200,000 health plan members since its IPO in March 2021. Both appointments aim to strengthen Alignment's care management and service delivery approach, integrating technology with compassionate care for seniors.
Alignment Healthcare (NASDAQ: ALHC) has scheduled the release of its first quarter 2025 financial results for Thursday, May 1, 2025, after market close. The company will host a conference call at 5 p.m. EDT to discuss the results.
Investors and interested parties can access a live audio webcast of the conference call through the company's investor relations website at https://ir.alignmenthealth.com/. The webcast replay will be available for approximately 12 months after the call.
Sutter Health and Alignment Healthcare (NASDAQ: ALHC) have renewed their strategic partnership, ensuring continued in-network access to Sutter's healthcare network for Alignment's Medicare Advantage members in Northern California. The agreement covers members enrolled in Sutter Advantage HMO and My Choice PPO health plans across 10 counties.
Sutter Health plans to expand its healthcare infrastructure starting in 2025, including:
- 27 new ambulatory care sites
- 27 urgent care centers
- 22 ambulatory surgery centers
The collaboration combines Sutter Health's provider network with Alignment's care model and AVA® technology platform, focusing on serving high-risk individuals with chronic conditions. The partnership spans across Placer, Sacramento, San Francisco, San Joaquin, San Mateo, Santa Clara, Santa Cruz, Sonoma, Stanislaus, and Yolo counties.
Alignment Healthcare (NASDAQ: ALHC) has announced its upcoming participation in two major healthcare conferences in March 2025. The company will present at the Leerink Global Healthcare Conference on Tuesday, March 11, at 3:40 p.m. EDT, followed by a presentation at the KeyBanc Capital Markets Healthcare Forum on Wednesday, March 19, at 10:30 a.m. EDT.
Both presentations will be accessible via webcast, with replays available on Alignment's investor relations website at ir.alignmenthealth.com.
Alignment Healthcare (ALHC) reported strong growth in its Q4 and full-year 2024 results. Health plan membership reached 189,100 as of December 31, 2024, marking a 58.6% increase year-over-year. The company achieved its first full year of positive adjusted EBITDA as a public company.
Q4 2024 highlights include total revenue of $701.2 million, up 50.7% year-over-year, with a medical benefits ratio of 87.5%. The company recorded an adjusted EBITDA of $1.4 million, despite a net loss of $(31.1) million.
For full-year 2024, total revenue reached $2,703.6 million, increasing 48.3% year-over-year, with an adjusted EBITDA of $1.3 million and a net loss of $(128.1) million. Looking ahead, ALHC provided 2025 revenue guidance of $3.72-3.78 billion, projecting 37.6-39.6% growth, with adjusted EBITDA expected between $35-60 million.
FAQ
What is the current stock price of Alignment Healthcare (ALHC)?
What is the market cap of Alignment Healthcare (ALHC)?
